Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cellsSandrine Bouchet(Inserm), Brigitte Bauvois(Inserm)OncotargetFebruary 18, 201410.18632/oncotarget.1788Cited by 15SaveCiteExport RISWatch citationsRelated PapersAminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospects|Medicinal Research Reviews|2005|265ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia|Leukemia|2023|30